MedPath

TENGION

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
2003-01-01
Employees
-
Market Cap
-
Website
http://www.tengion.com/

A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes

Phase 1
Terminated
Conditions
Chronic Kidney Disease
Interventions
Biological: Neo-kidney augment
First Posted Date
2013-12-11
Last Posted Date
2014-12-11
Lead Sponsor
Tengion
Target Recruit Count
1
Registration Number
NCT02008851
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago Medicine, Chicago, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

LSU Health Care Services, New Orleans, Louisiana, United States

๐Ÿ‡บ๐Ÿ‡ธ

UNC Medical Center, Chapel Hill, North Carolina, United States

and more 2 locations

Study of an Autologous Neo-Kidney Augment in Patients With Chronic Kidney Disease

Phase 1
Terminated
Conditions
Chronic Kidney Disease
Interventions
Biological: Implantation of SRC
First Posted Date
2013-05-03
Last Posted Date
2014-12-11
Lead Sponsor
Tengion
Target Recruit Count
6
Registration Number
NCT01846715
Locations
๐Ÿ‡ธ๐Ÿ‡ช

Karolinska Institute, Stockholm, Sweden

๐Ÿ‡ธ๐Ÿ‡ช

Uppsala University Hospital, Uppsala, Sweden

Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit

Phase 1
Completed
Conditions
Bladder Cancer
Interventions
Device: Neo-Urinary Conduit
First Posted Date
2010-03-16
Last Posted Date
2014-12-10
Lead Sponsor
Tengion
Target Recruit Count
8
Registration Number
NCT01087697
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Baylor College of Medicine, Houston, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Brigham and Women's Hospital, Boston, Massachusetts, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Michigan Health System, Ann Arbor, Michigan, United States

and more 3 locations

Multi Center Study to Obtain Bladder Tissue Specimens From Patients Undergoing Transurethral Resection Biopsy Procedure

Completed
Conditions
Bladder Disease
Interventions
Procedure: Bladder biopsy
First Posted Date
2008-02-14
Last Posted Date
2010-12-22
Lead Sponsor
Tengion
Target Recruit Count
6
Registration Number
NCT00615043
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Alabama, Birmingham, Birmingham, Alabama, United States

Autologous Neo-Bladder Construct in Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence

Phase 2
Withdrawn
Conditions
Overactive Bladder
Interventions
Biological: Autologous neobladder construct
First Posted Date
2008-01-15
Last Posted Date
2018-06-08
Lead Sponsor
Tengion
Registration Number
NCT00594139
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Vanderbilt University, Nashville, Tennessee, United States

Study to Obtain Full Thickness Bladder Tissue From Subjects Undergoing Cystectomy Surgery

Completed
Conditions
Cystectomy
Interventions
Other: tissue procurement
First Posted Date
2007-12-20
Last Posted Date
2010-12-22
Lead Sponsor
Tengion
Target Recruit Count
52
Registration Number
NCT00577785
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Southern California, Los Angeles, California, United States

Study of Autologous Neo-Bladder Construct in Subjects With Neurogenic Bladder Following Spinal Cord Injury

Phase 2
Terminated
Conditions
Neurogenic Bladder
Interventions
Device: Autologous neobladder construct
First Posted Date
2007-08-07
Last Posted Date
2018-08-17
Lead Sponsor
Tengion
Target Recruit Count
7
Registration Number
NCT00512148
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Augmentation Cystoplasty Using an Autologous Neo-Bladder

Phase 2
Terminated
Conditions
Neurogenic Bladder
Interventions
Biological: Autologous neo bladder construct
First Posted Date
2007-01-08
Last Posted Date
2015-11-30
Lead Sponsor
Tengion
Target Recruit Count
10
Registration Number
NCT00419120
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Boston Childrens Hospital, Boston, Massachusetts, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath